NEO

Q: What is the price of NeoGenomics (NEO) today?

The current price of NeoGenomics (NEO) is $ 11.15, representing a 57.71% gain over the past year. The stock began the year trading around $ 11.76 and is currently priced at $ 11.15. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

Q: When does NeoGenomics (NEO) pay dividends?

NeoGenomics (NEO) did not pay dividends over the past year.

Q: Is NeoGenomics (NEO) a good investment?

NeoGenomics (NEO) is currently trading at $ 11.15 with a P/E ratio of -14.50. This represents a -1,752% premium compared to its historical average P/E. Over the past year, the stock has gained 57.71 and paid $ 0.00 in dividends, resulting in a dividend yield of 0.00%. The total shareholder return over the same period was 57.71%.Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

NeoGenomics Inc.

Price

$ 11.15

return (12m)

57.71%

p/e

-14.50

p/bv

1.74

DIVIDEND YIELD

0.00%

NEO price

NeoGenomics

If you had invested

exposure

years ago

7 days

30 days

6 months

YTD

1 year

5 years

10 years

15 years

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment NEO

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

33.37%

3 months

41.50%

1 year

57.71%

2 years

-16.92%

5 years

-74.42%

10 years

42.32%

Fundamentals NEO

review the fundamentals of NeoGenomics shares

P/E

-14.50

Sector: -2.40 Industry: 7.44

P/S (PSR)

1.93

Sector: 1.94 Industry: 3.07

P/BV

1.74

Sector: 2.11 Industry: 3.12

DIVIDEND YIELD (DY)

0.00%

Sector: - Industry: -

ROA

-7.37%

Sector: -28.57% Industry: -3.96%

ROE

-11.97%

Sector: -35.14% Industry: -15.35%

ROIC

-6.10%

Sector: -439.49% Industry: -13.19%

NET MARGIN

-13.30%

Sector: -31.27% Industry: -7.51%

GROSS MARGIN

43.15%

Sector: 44.47% Industry: 54.39%

OPERATING MARGIN

-10.53%

Sector: -26.20% Industry: -3.69%

EV/EBITDA

-43.65

Sector: -0.60 Industry: 7.50

EV/EBIT

-14.46

Sector: -2.30 Industry: 7.06

PRICE-TO-ASSETS

1.07

Sector: 1.14 Industry: 1.27

BVPS

6.42

Sector: 3.75 Industry: 8.68

EPS

-0.77

Sector: -0.94 Industry: 0.05

EQUITY-TO-ASSETS RATIO

0.62

Sector: 0.43 Industry: 0.48

LIABILITIES / ASSETS

0.38

Sector: 0.46 Industry: 0.52

CAGR REVENUE 5 YEARS

9.02%

Sector: - Industry: -

CAGR PROFIT 5 YEARS

64.05%

Sector: - Industry: -

Fundamentals NEO

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
LLY	40.12	32.50	81.02%	0.57%	$ 1.01 T	34.99%
ISRG	48.98	8.29	16.93%	0.00%	$ 145.93 B	28.15%
SNY	7.23	1.29	17.79%	3.99%	$ 108.01 B	14.75%
TMO	25.50	3.35	13.15%	0.38%	$ 174.59 B	15.15%
NVS	21.59	7.51	34.77%	2.03%	$ 292.21 B	23.92%
ABT	23.76	2.83	11.91%	2.85%	$ 149.12 B	13.91%
MDT	21.42	0.00	-%	3.54%	$ 102.82 B	13.20%
GSK	13.49	4.56	33.77%	3.33%	$ 105.82 B	17.79%
CVS	44.27	1.67	3.78%	2.61%	$ 129.80 B	0.72%
BSX	19.67	2.71	13.78%	0.00%	$ 70.13 B	17.29%
TMDX	14.42	5.02	34.80%	0.00%	$ 2.48 B	27.04%
IDXX	40.97	28.84	70.38%	0.00%	$ 44.87 B	24.63%
HCA	12.77	-29.12	-228.14%	0.76%	$ 86.73 B	8.89%
RMD	18.53	4.34	23.41%	0.93%	$ 28.16 B	27.44%
DHR	34.57	2.41	6.97%	0.76%	$ 127.51 B	14.89%
INMD	9.72	1.28	13.18%	0.00%	$ 847.35 M	23.27%
PHG	22.29	1.91	8.56%	3.83%	$ 25.19 B	5.50%
SYK	35.73	5.19	14.52%	1.11%	$ 119.24 B	13.21%
CI	12.12	1.87	15.39%	2.04%	$ 78.74 B	2.34%

Stock vs Indice Comparison Tool

If you had invested

years ago

2 years

5 years

10 years

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

NEO Historical Dividends

current DY: 0.00%

5-year average DY: 0.23%

DRAG THE FRAME TO SEE MORE DATA

type	Ex - Dividend Date	payment date	value
Dividends	12/16/2020	12/30/2020	0,40000000

ABOUT NeoGenomics

NeoGenomics Inc.

Average Investor10 user rating

4.0 (1 people)

United States

28 years

Founded: 1998

1996

Time since IPO - 30 years

1.700

Employees

NeoGenomics Inc. (United States) is listed on the Nasdaq and has a market capitalization of $1.44 Billion, with shareholders equity totaling $828.76 Millions.

The company employs approximately 1.700 people and operates in the Health sector, within the Health Establishments industry.

Over the past 12 months, NeoGenomics Inc. reported $745.97 Millions in revenue, generating net income of $-99.21 Millions.

Key financial metrics include a P/E ratio of -14.50, a price-to-book (P/B) ratio of 1.74, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker NEO.

Market cap

$ 1.44 Billion

Net worth

$ 828.76 Millions

$ 828,760,000.00

Assets

$ 1.35 Billion

$ 1,346,530,000.00

Total Shares Outstanding

129.00 Millions

129,000,000

Average Daily Trading Volume

$ 1.99 Million

$ 1,989,962.00

Sector

Health

Industry

Health Establishments

NEO

NEO revenue and profits

Financial Results NEO

DRAG THE FRAME TO SEE MORE DATA

NEO cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more stocks

CVS - CVS Health

$ 101.96 56,65% (12M)

P/E

44.27

2.61%

ROE

3.78%

P/BV

1.67

CI - Cigna

$ 298.00 --4,13% (12M)

P/E

12.12

2.04%

ROE

15.39%

P/BV

1.87

CNC - Centene

$ 65.19 18,06% (12M)

P/E

-4.98

0.00%

ROE

-29.93%

P/BV

1.49

HUM - Humana

$ 379.22 63,73% (12M)

P/E

40.27

0.93%

ROE

6.06%

P/BV

2.44

SNY - Sanofi

$ 44.25 --7,40% (12M)

P/E

7.23

3.99%

ROE

17.79%

P/BV

1.29

LLY - Eli Lilly

$ 1,133.00 41,29% (12M)

P/E

40.12

0.57%

ROE

81.02%

P/BV

32.50

HCA - HCA Healthcare

$ 387.18 5,20% (12M)

P/E

12.77

0.76%

ROE

-228.14%

P/BV

-29.12

NVS - Novartis

$ 153.07 30,64% (12M)

P/E

21.59

2.03%

ROE

34.77%

P/BV

7.51

CVS - CVS Health

$ 101.96 56,65% (12 M)

P/L

44.27

2.61%

ROE

3.78%

P/VP

1.67

CI - Cigna

$ 298.00 --4,13% (12 M)

P/L

12.12

2.04%

ROE

15.39%

P/VP

1.87

CNC - Centene

$ 65.19 18,06% (12 M)

P/L

-4.98

0.00%

ROE

-29.93%

P/VP

1.49

HUM - Humana

$ 379.22 63,73% (12 M)

P/L

40.27

0.93%

ROE

6.06%

P/VP

2.44

SNY - Sanofi

$ 44.25 --7,40% (12 M)

P/L

7.23

3.99%

ROE

17.79%

P/VP

1.29

LLY - Eli Lilly

$ 1,133.00 41,29% (12 M)

P/L

40.12

0.57%

ROE

81.02%

P/VP

32.50

HCA - HCA Healthcare

$ 387.18 5,20% (12 M)

P/L

12.77

0.76%

ROE

-228.14%

P/VP

-29.12

NVS - Novartis

$ 153.07 30,64% (12 M)

P/L

21.59

2.03%

ROE

34.77%

P/VP

7.51

Frequently Asked Questions

What is the price of NeoGenomics (NEO) today?

The current price of NeoGenomics (NEO) is $ 11.15, representing a 57.71% gain over the past year. The stock began the year trading around $ 11.76 and is currently priced at $ 11.15. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

When does NeoGenomics (NEO) pay dividends?

NeoGenomics (NEO) did not pay dividends over the past year.

Is NeoGenomics (NEO) a good investment?

NeoGenomics (NEO) is currently trading at $ 11.15 with a P/E ratio of -14.50. This represents a -1,752% premium compared to its historical average P/E. Over the past year, the stock has gained 57.71 and paid $ 0.00 in dividends, resulting in a dividend yield of 0.00%. The total shareholder return over the same period was 57.71%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy NeoGenomics (NEO) stock?

You can buy NeoGenomics (NEO) shares through any brokerage account that provides access to U.S. stock exchanges. After opening and funding your account, simply search for the ticker symbol NEO and place a buy order. Before investing, consider factors such as your financial goals, risk tolerance, and overall portfolio allocation.

How much would 100 shares of NeoGenomics (NEO) yield today?

Over the past month, NeoGenomics (NEO) has returned 33.37% — 57.71% over the past year, and -74.42% over the past five years, including price appreciation and dividends.

In the last 12 months, the company paid a total of 0.00 per share in dividends, resulting in a dividend yield of 0.00%.

If you were to purchase 100 shares of NeoGenomics (NEO) today at the current price of $ 11.15 your total investment would be $ 1,115.00.

Based on historical performance, the investment would have grown to approximately:

$ 1,758.47 after 1 year
$ 285.22 after 5 years
$ 1,586.87 after 10 years

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

NEO

NeoGenomics Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment NEO

review the fundamentals of NeoGenomics shares

P/E

P/S (PSR)

P/BV

DIVIDEND YIELD (DY)

ROA

ROE

ROIC

NET MARGIN

GROSS MARGIN

OPERATING MARGIN

EV/EBITDA

EV/EBIT

PRICE-TO-ASSETS

BVPS

EPS

EQUITY-TO-ASSETS RATIO

LIABILITIES / ASSETS

CAGR REVENUE 5 YEARS

CAGR PROFIT 5 YEARS

current DY: 0.00%

5-year average DY: 0.23%

type

Ex - Dividend Date

payment date

value

ABOUT NeoGenomics

NeoGenomics Inc.

United States

28 years

1996

1.700

PROFIT X PRICE NEO

Financial Results NEO

NEO cash flow

Asset, Revenue and Profit Growth - NEO

NEO balance sheet

CVS - CVS Health

CI - Cigna

CNC - Centene

HUM - Humana

SNY - Sanofi

LLY - Eli Lilly

HCA - HCA Healthcare

NVS - Novartis

CVS - CVS Health

CI - Cigna

CNC - Centene

HUM - Humana

SNY - Sanofi

LLY - Eli Lilly

HCA - HCA Healthcare

NVS - Novartis

Frequently Asked Questions